Biogen stock has mostly trended sideways this year, but that could soon change with up to $10 billion in dry powder, an analyst said Tuesday.

The post Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense appeared first on Investor’s Business Daily.